Eye Health News and Research

Latest Eye Health News and Research

New device tracks chemical messages that regulate cell growth

New device tracks chemical messages that regulate cell growth

IQWiG examines added benefit of aflibercept in macular oedema after branch retinal vein occlusion

IQWiG examines added benefit of aflibercept in macular oedema after branch retinal vein occlusion

'Bionic eye' improves visual function, quality of life for people with retinitis pigmentosa

'Bionic eye' improves visual function, quality of life for people with retinitis pigmentosa

Scientific collaboration pinpoints genetic cause of rare form of blindness in newborn babies

Scientific collaboration pinpoints genetic cause of rare form of blindness in newborn babies

Steady rise in obesity, excess weight also signals upward swing in chronic health conditions

Steady rise in obesity, excess weight also signals upward swing in chronic health conditions

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

Israeli researchers establish novel optogenetic method for cardiac pacing and resynchronization

Israeli researchers establish novel optogenetic method for cardiac pacing and resynchronization

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Oraya IRay Radiotherapy System for AMD treatment receives Silver award at MDEA 2015

Nonmotor features may predict PD progression

Nonmotor features may predict PD progression

OphthaliX enters into definitive agreement to purchase Improved Vision Systems

OphthaliX enters into definitive agreement to purchase Improved Vision Systems

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS

University of Delaware researchers identify prime suspects in cataract formation

University of Delaware researchers identify prime suspects in cataract formation

CellResearch receives new patent approval from USPTO for stem cell technology

CellResearch receives new patent approval from USPTO for stem cell technology

Johns Hopkins researchers develop new imaging technology to help remove brain tumors safely

Johns Hopkins researchers develop new imaging technology to help remove brain tumors safely

New study launched in Liberia to better understand health consequences of Ebola virus disease

New study launched in Liberia to better understand health consequences of Ebola virus disease

UW microbiologist receives 2015 Shaw Prize in life science and medicine

UW microbiologist receives 2015 Shaw Prize in life science and medicine

Injectable drug ocriplasmin improves vision in patients with symptomatic vitreomacular adhesion

Injectable drug ocriplasmin improves vision in patients with symptomatic vitreomacular adhesion

Ruhr-Universität Bochum scientists develop mouse model to investigate SCA6

Ruhr-Universität Bochum scientists develop mouse model to investigate SCA6

JAMA: Extremely preterm infants enrolled in randomized clinical trials experience neither better nor worse outcomes

JAMA: Extremely preterm infants enrolled in randomized clinical trials experience neither better nor worse outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.